Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
By stimulating two hormone pathways, it enhances insulin secretion, more effectively suppresses appetite, and supports a greater reduction in blood sugar levels
N., Pryor, K
The same drug has now been approved under a new brand name, Saxenda, as an adjunct treatment for obesity
It is administered as a weekly subcutaneous injection, available in doses from 2.5 mg up to 15 mg, typically titrated upward over several months
:format(webp))
China GLP-1 Receptor Agonist Market Analysis and Trends China represents a major emerging market, driven by an increasing diabetes burden, expanding healthcare access, and supportive government initiatives
US$ 23.61
US$ 21.27
US$ 22.14
US$ 27.42
US$ 20.49
US$ 24.06
